Last reviewed · How we verify
NCT04109612: SUN4P
Improving Stroke Care in Greece in Terms of Management, Costs and Health Outcomes-
trial in Cerebrovascular Disorders in 913 participants. Completed in 13 January 2022.
30 October 2021
Quick facts
| Lead sponsor | National and Kapodistrian University of Athens |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 913 |
| Start date | 17 July 2019 |
| Primary completion | 30 October 2021 |
| Estimated completion | 13 January 2022 |
| Sites | 10 locations across Greece |
Conditions studied
- Cerebrovascular Disorders — all drugs for Cerebrovascular Disorders →
Sponsor
National and Kapodistrian University of Athens
Who can join
18 and older, any sex, with Cerebrovascular Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objectives of the proposed project are: 1. To provide essential data on acute stroke management (quality indicators) incorporating hard clinical outcomes that will contribute to an ongoing process of quality improvement 2. To develop an interactive multichannel platform, for collecting, cleansing and curating high quality in-hospital and follow up data, applying multidimensional quality assessment analysis, providing statistical and analytic reports, monitoring behavioral changes and supporting overall project's management. 3. To evaluate patients' and physicians' experiences and their impact on stroke management. 4. To assess severe negative impact of stroke on the life of survivors including quality of life and disability 5. To measure health related and non- health (loss of productivity, informal care) related national expenditure for stroke care using a bottom up approach 6. To evaluate the value of care focusing on health outcomes compared with total costs of achieving them
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Quality Indicators and Clinical Outcomes of Acute Stroke: Results from a Prospective Multicenter Registry in Greece (SUN4P).
Korompoki E, Ntaios G, Tountopoulou A, Mavraganis G, et al · · 2024 · cited 7× · PMID 38337611 · DOI 10.3390/jcm13030917 -
The Cost and the Value of Stroke Care in Greece: Results from the SUN4P Study.
Siskou O, Galanis P, Konstantakopoulou O, Stafylas P, et al · · 2023 · cited 3× · PMID 37761742 · DOI 10.3390/healthcare11182545
Verify or expand the search:
- PubMed search for NCT04109612
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebrovascular Disorders
Currently open trials in the same condition.
- NCT07185022 — Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion · NA · recruiting
- NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
- NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
- NCT07167550 — The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke · Phase 3 · recruiting
- NCT07140601 — Environmental Pollutants and Neurological Disorders · recruiting
Other National and Kapodistrian University of Athens trials
Trials by the same sponsor.
- NCT07295964 — Accuracy of Intraoral Scan Post-processing Methods: A Clinical Trial · NA · not yet recruiting
- NCT07351981 — TcPRF for Knee Osteoarthritis · NA · enrolling by invitation
- NCT07477496 — Recurrence and Anal Fistula Patient Reported Outcomes Trial · recruiting
- NCT07295899 — Assessing the Influence of Implant Scanning Techniques on the Accuracy of Maxillary Complete-Arch Digital Scans for Impl · not yet recruiting
- NCT06903130 — Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sN · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04109612 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National and Kapodistrian University of Athens
- Last refreshed: 13 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04109612.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing